1. Home
  2. GNFT vs INGN Comparison

GNFT vs INGN Comparison

Compare GNFT & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • INGN
  • Stock Information
  • Founded
  • GNFT 1999
  • INGN 2001
  • Country
  • GNFT France
  • INGN United States
  • Employees
  • GNFT N/A
  • INGN N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • INGN Industrial Specialties
  • Sector
  • GNFT Health Care
  • INGN Health Care
  • Exchange
  • GNFT Nasdaq
  • INGN Nasdaq
  • Market Cap
  • GNFT 249.0M
  • INGN 260.2M
  • IPO Year
  • GNFT 2019
  • INGN 2014
  • Fundamental
  • Price
  • GNFT $6.06
  • INGN $8.99
  • Analyst Decision
  • GNFT Strong Buy
  • INGN Hold
  • Analyst Count
  • GNFT 1
  • INGN 4
  • Target Price
  • GNFT $13.00
  • INGN $7.00
  • AVG Volume (30 Days)
  • GNFT 26.3K
  • INGN 190.5K
  • Earning Date
  • GNFT 09-19-2024
  • INGN 11-05-2024
  • Dividend Yield
  • GNFT N/A
  • INGN N/A
  • EPS Growth
  • GNFT N/A
  • INGN N/A
  • EPS
  • GNFT 0.47
  • INGN N/A
  • Revenue
  • GNFT $86,225,222.00
  • INGN $326,653,000.00
  • Revenue This Year
  • GNFT $155.44
  • INGN $5.76
  • Revenue Next Year
  • GNFT N/A
  • INGN $4.10
  • P/E Ratio
  • GNFT $12.34
  • INGN N/A
  • Revenue Growth
  • GNFT 175.45
  • INGN N/A
  • 52 Week Low
  • GNFT $2.97
  • INGN $4.13
  • 52 Week High
  • GNFT $6.08
  • INGN $13.33
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 69.91
  • INGN 26.20
  • Support Level
  • GNFT $5.41
  • INGN $8.85
  • Resistance Level
  • GNFT $5.84
  • INGN $9.33
  • Average True Range (ATR)
  • GNFT 0.30
  • INGN 0.39
  • MACD
  • GNFT 0.04
  • INGN -0.06
  • Stochastic Oscillator
  • GNFT 98.03
  • INGN 13.71

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: